Brief: Oncternal Therapeutics -On Oct 3, Nasdaq Notified That It Has Granted Co Additional 180 Calendar Days To Regain Compliance With Minimum Bid Requirement
06/10/2023 21:41
Oct 6 (Reuters) - Oncternal Therapeutics Inc ONCT.O :
* ONCTERNAL THERAPEUTICS -ON OCT 3, NASDAQ NOTIFIED THAT IT
HAS
GRANTED CO ADDITIONAL 180 CALENDAR DAYS TO REGAIN COMPLIANCE
WITH MINIMUM BID REQUIREMENT
Further company coverage: ONCT.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;